Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 701-427-1 | CAS number: -
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Link to relevant study record(s)
Description of key information
The dermal absorption of Modified Small Vinyl Ester was calculated using results for constituents from QSAR estimations with US-EPA Dermwin v2.01. The constituents bisGMA, monomaleic-bisGMA, oligomeric reaction products, epoxy-monoGMA, and dihydroxy-monoGMA all are calculated to have low to negligible individual dermal absorption rates - below 0.2%. The highest value is for dihydroxy-bisGMA, being 0.19% .
The residual methacrylic acid (<0.5%) is rapidly absorbed through the skin. The relative dermally absorbed doses are calculated to 18, 95 and 100%, respectively at contact times of 1-hour, 8-hours and 24-hours. The calculated systemic dose at 24-hours contact to both hands and forearms (1980 cm2) is 45 mg/kg bw, which approximately 12 times lower than the lowest NOAEL found in mice in repeated exposure toxicity studies (ca. 550 mg/kg bw/d).
Epoxy-monoGMA, dihydroxy-monoGMA and the residual methacrylic acid account for only a maximum of 5%, 5% and 1% of the composition, respectively. Their contribution to the overall dermal absorption is evaluated to be insignificant due their low concentrations. Thus, the overall dermal absorptions for Modified Small Vinyl Ester based on constituents bisGMA, monomaleic-bisGMA, and the oligomeric part, accounting for approximately 98% of Modified Small Vinyl Ester, are less than 3*10-5%, 8*10-5%, and 1.4*10-4%, for 1-hour, 8-hour, and 24-hour dermal contact times, respectively. The oligomeric part is evaluated not to be absorbed through the skin. Thus, the overall relative dermal absorption for Modified Small Vinyl Ester is less the 0.00014%.
It is evaluated that dermal absorption of Modified Small Vinyl Ester is negligible and consequently that Modified Small Vinyl Ester is not systemically bioavailable by skin contact
Key value for chemical safety assessment
- Absorption rate - dermal (%):
- 0
Additional information
The dermal absorption of Modified Small Vinyl Ester was calculated using results for the main compounds from QSAR estimations with US-EPA Dermwin v2.01. The relative absorption rates for Modified Small Vinyl Ester were calculated for three exposure times (1 h, 8 h and 24 h). For the constituents bisGMA, monomaleic-bisGMA, epoxy-monoGMA, and dihydroxy-monoGMA, the individual relative dermal absorption rates for calculated on the basis of QSAR estimations to be lower than 0.2% at 24 h contact time for dihydroxy-monoGMA and even lower for bisGMA and epoxy-monoGMA, and for the shorter contact times. The oligomeric part is evaluated not to be absorbed through the skin.
Only for the residual methacrylic acid (<0.5%) the relative absorption rate is not negligible; which was calculated to 18, 95 and 100%, respectively for the three exposure times. However, it should be noted that for contact with both hands and forearms (11% of the body surface of a human weighing 70 kg bw) the dermally absorbed doses of methacrylic acid using the US-EPA model are estimated to 3, 16 and 45 mg/kg bw, respectively for the contact periods of 1-hour, 8-hours and 24-hours. The latter dose is approximately 12 times lower than the lowest NOAEL for methacrylic acid found in mice in repeated exposure toxicity studies (ca. 550 mg/kg bw/d).
Epoxy-monoGMA, dihydroxy-monoGMA and the residual methacrylic acid account for only a maximum of 5%, 5% and 1% of the composition, respectively. Their contribution to the overall dermal absorption is evaluated to be insignificant due their low concentrations. Thus, the overall dermal absorptions for Modified Small Vinyl Ester based on constituents bisGMA, monomaleic-bisGMA and the oligomeric part, accounting for approximately 98% of the substance, are less than 3*10-5%, 8*10-5%, and 1.4*10-4%, for 1-hour, 8-hour, and 24-hour dermal contact times, respectively. The oligomeric part is evaluated not to be absorbed through the skin. Thus, the overall relative dermal absorption for Modified Small Vinyl Ester is less the 0.00014%.
It is evaluated that dermal absorption of Modified Small Vinyl Ester is negligible and consequently that Modified Small Vinyl Ester is not systemically bioavailable by skin contact.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.